Qatari German Company for Medical Devices QPSC

The company's capital structure is highly leveraged, with a debt-to-equity ratio of 3.91, indicating a significant reliance on debt financing. Its liquidity position is weak, as evidenced by a current ratio of 0.49, suggesting that the company may struggle to meet short-term obligations without external financing. The return on equity of 0.78% and return on assets of 0.14% are well below the industry median for medical equipment and distribution firms, indicating subpar capital efficiency and asset utilization.

Profitability metrics show a gross margin of 55.56% (3,292,510 QAR gross profit on 5,926,100 QAR revenue), which is in line with the industry average for medical equipment firms. However, the operating margin of 9.55% (566,960 QAR operating income) and net margin of 4.80% (284,450 QAR net income) are below the industry median, suggesting inefficiencies in cost control or pricing power. The company's net income is also below the cohort median for its industry, indicating a weaker earnings profile relative to peers.

The company's revenue is concentrated in a single geographic market, with no disclosed segment breakdown, making it highly sensitive to regional economic and regulatory shifts. There is no indication of diversification into international markets or product lines, which limits its growth potential and exposes it to localized risks.

The company's revenue growth trajectory is uncertain, with no disclosed historical growth rates or forward-looking guidance. Analyst estimates for the most recent period show a revenue of 46,000 QAR, which is significantly lower than the reported revenue of 5,926,100 QAR, suggesting potential data inconsistencies or a mismatch in reporting periods. The negative EPS of -0.05 QAR indicates a loss per share, which is a red flag for investors.

The company faces moderate liquidity risk due to its weak current ratio and high debt load. The risk assessment indicates a medium liquidity risk and a low dilution risk, but the negative net cash position after subtracting total debt raises concerns about its ability to service obligations without further financing. No recent dilutive events are disclosed, but the high debt-to-equity ratio suggests that the company may need to issue equity or take on more debt to fund operations or growth.

No recent filings or transcripts are available in the provided data, so the company's strategic direction and operational performance cannot be assessed based on management commentary or investor relations updates.

Revenue QAR 1.6M, +116,8% YoY; Operating income +107,5% YoY.

• ▍Revenue QAR 1.6M, +116,8% YoY
• ▍Operating income +107,5% YoY
• ▍Net income +106,3% YoY
• ▍Net margin 275.7%

Revenue QAR 1.6M; Operating income QAR 798.3k.

• ▍Revenue QAR 1.6M
• ▍Operating income QAR 798.3k
• ▍Net margin 35.6%

Revenue QAR 717.9k; Operating income -QAR 57.3M.

• ▍Revenue QAR 717.9k
• ▍Operating income -QAR 57.3M
• ▍Net margin -9425.0%

Revenue QAR 1.2M, −27,7% YoY; Operating income +61,9% YoY.

• ▍Revenue QAR 1.2M, −27,7% YoY
• ▍Operating income +61,9% YoY
• ▍Net income +53,0% YoY
• ▍Net margin -63.8%

Revenue QAR 1.1M, −81,1% YoY; Operating income −346,7% YoY.

• ▍Revenue QAR 1.1M, −81,1% YoY
• ▍Operating income −346,7% YoY
• ▍Net income −660,8% YoY
• ▍Net margin -142.5%

Revenue QAR 1.7M; Operating income -QAR 1.5M.

• ▍Revenue QAR 1.7M
• ▍Operating income -QAR 1.5M
• ▍Net margin -98.0%

Revenue QAR 5.9M; Operating income QAR 567.0k.

• ▍Revenue QAR 5.9M
• ▍Operating income QAR 567.0k
• ▍Net margin 4.8%

Revenue QAR 10.0M, −64,2% YoY; Operating income −1 504,2% YoY.

• ▍Revenue QAR 10.0M, −64,2% YoY
• ▍Operating income −1 504,2% YoY
• ▍Net income −5 226,3% YoY
• ▍Free cash flow −1 235,2% YoY
• ▍Net margin -685.9%